Skip to main content

Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

4.46 +0.17 (3.96%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/01/20NeedhamDowngradesHold
5/28/20Cantor FitzgeraldMaintainsOverweight24.0
10/21/19NeedhamInitiates Coverage OnBuy18.0
9/16/19JefferiesAssumesHold11.0
4/30/19Roth CapitalInitiates Coverage OnBuy
4/22/19Canaccord GenuityAssumesBuy18.0
9/21/18Cantor FitzgeraldInitiates Coverage OnOverweight21.0
8/03/18Canaccord GenuityMaintainsBuy15.0
2/01/18H.C. WainwrightAssumesBuy23.0
1/29/18Ladenburg ThalmannInitiates Coverage OnBuy25.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter